Vanda Pharmaceuticals Other Long Term Liabilities (Quarterly) Insights

Vanda Pharmaceuticals, Inc. (VNDA)

8.03 +2.27 (+39.41%) USD | NASDAQ | Feb 23, 12:16

View Other Long Term Liabilities (Quarterly) for VNDA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Axsome Therapeutics, Inc.	Upgrade
AnaptysBio, Inc.	Upgrade
SELLAS Life Sciences Group, Inc.	--
Protagenic Therapeutics, Inc.	--